Skip to main content
. Author manuscript; available in PMC: 2015 Jun 25.
Published in final edited form as: Chem Commun (Camb). 2014 Apr 7;50(39):5027–5030. doi: 10.1039/c4cc01199f

Figure 2.

Figure 2

Characterization data for representative compounds of Table 1. (A) SPR-based inhibition curves corresponding to disruption of HDM2/p53 interaction; (B) Circular dichroism spectra measured in phosphate buffer (pH 7.0) with 40% TFE; (C) Proteolytic stability tests in the presence of chymotrypsin (1.0 μg / mL) at room temperature.